Guaifenesin DM
NDC 60687-817, Guaifenesin and Dextromethorphan, syrup, from American Health Packaging.
- Product NDC
- 60687-817
- Status
- Listed
- Labeler
- American Health Packaging
- Dosage form
- SYRUP
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60687-817 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN100 mg/5mL
- DEXTROMETHORPHAN10 mg/5mL
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60687-817-17 | 60687081717 | 10 TRAY in 1 CASE (60687-817-17) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-817-46) / 5 mL in 1 CUP, UNIT-DOSE (60687-817-40) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 60687-817 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60687-817 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60687-817. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.